Track topics on Twitter Track topics that are important to you
The first few years of the new Millennium have been particularly difficult for Biotechnology companies, particularly those in the Biopharmaceutical sector.
Apart from the well recognised difficulties in acquiring funding, one of the major reasons for these companies failing to succeed is their poor understanding, and equally that of their funding partners, of the fundamental difference between Research and Development and of the specialist skills needed to support companies in the transition from "R to D". The effective management of this transition is critical to the whole commercialisation process for biopharmaceutical products.
Wallace Building Roslin BioCentre
Phone: 44 (0) 131 200 6388
Fax: 44 (0) 131 200 6390
From BIO-Europe, the biggest pharma and biotech partnering meeting in Europe, Scrip lists the five hottest topics of discussion and...
(Potsdam Institute for Climate Impact Research (PIK)) Rising temperatures due to greenhouse gas emissions will fundamentally change electricity consumption patterns in Europe. A team of scientists fro...
I interviewed Kate Bingham of SV Health Investors about Alzheimer’s, checkpoint inhibitors, gender diversity and more at BIO Europe. BIO Europe 2017 was off to a racing start on Monday morning w...
By Antonio Parrinello and Steve Scherer CATANIA, Italy (Reuters) - A dozen far-right millennials from Europe and North America plan to set sail next week to "defend Europe" from what they call a migr...
Analysts predict Kymriah could become a $1bn-plus product in Europe
Families from across Europe are on Tuesday having their say on an epilepsy drug that raises the risk…
Hackers have caused widespread disruption across Europe, hitting Ukraine especially hard.
Drug becomes first targeted biologic in Europe to treat moderate-to-severe atopic dermatitis (AP)
Nizatidine Capsules USP Rx only
MANICURE by OPI FINISHING BUTTER
Retavase Reteplase, recombinant
Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...
The proportion of females among neurosurgeons appears to be growing worldwide with time. Official data concerning the current situation across Europe have not yet been published. Thus, there are still...
Are there any changes in the treatments involving ART and IUI initiated in Europe during 2013 compared with previous years?
The burden of cardiovascular disease is increasing worldwide, which has to be reflected by cardiovascular (CV) research in Europe. CardioScape, a FP7 funded project initiated by the European Society o...
To describe the infrastructural differences in training in Obstetrics and Gynaecology (ObGyn) across Europe.
This study is conducted in Europe. The aim of this study is to investigate usage of liraglutide for weight management in clinical practice.
This multicenter, prospective, single-arm, phase 3 study will assess the proportion of disease-free patients, starting from administration of the first study treatment to at least 12-month...
The investigators want to identify and show differences in standards and procedures of in-hospital rapid sequence induction by collecting data with an online survey for anaesthetist in Eur...
This is a prospective, non-interventional study (NIS) measuring health-related quality of life (HRQoL), treatment satisfaction, and other patient-reported outcomes (PROs) of ADPKD patients...
The main objective is to replicate the validation of omics biomarkers of left ventricular diastolic dysfunction in patients with metabolic syndrome. The aim was to recruit overall 750 pa...
Europe Unlimited profiles and connects the community of Europe’s best tech entrepreneurs and international capital through research, networking events and consulting. As such, we are in a position t...
âWe are the gateway to Europe for U.S.-based medical technology companies.â Rick Hughes, President, HealthLink Europe
TESCOM EUROPE offers customized solutions and services for all pressure and flow control applications. We design, engineer, manufacture and install components and automated systems for pressure and fl...
Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...
Sumitomo Corporation Europe is a principal subsidiary of Sumitomo Corporation, a leading integrated trading company with its headquarters in Japan, and as such we share in its key role in the exchange...
We have published hundreds of BCG (Europe) Ltd news stories on BioPortfolio along with dozens of BCG (Europe) Ltd Clinical Trials and PubMed Articles about BCG (Europe) Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BCG (Europe) Ltd Companies in our database. You can also find out about relevant BCG (Europe) Ltd Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...